A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2

Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peiqi Yin, Ling Zhang, Fei Ye, Yao Deng, Sha Lu, Yi-Ping Li, Leiliang Zhang, Wenjie Tan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/14a535e894574041ba6a7a01d70ccb93
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14a535e894574041ba6a7a01d70ccb93
record_format dspace
spelling oai:doaj.org-article:14a535e894574041ba6a7a01d70ccb932021-12-02T12:31:50ZA screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E210.1038/s41598-017-04274-82045-2322https://doaj.org/article/14a535e894574041ba6a7a01d70ccb932017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04274-8https://doaj.org/toc/2045-2322Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of overlapping peptides covering E1E2. Screening the peptide library identified several novel anti-HCV peptides. Four peptides from glycoprotein E2 were selected for further investigation. The 50% effective dose (ED50) was approximately 5 nM for each peptide. Our data indicated that these peptides inhibited HCV entry at the post-attachment step. Moreover, these peptides blocked cell-to-cell transmission of HCVcc and had broad-spectrum antiviral effects on HCVcc. These peptides exhibited combination inhibitory effects on HCVcc infection when combined with IFN-α2b or anti-CD81 antibody. Interestingly, we observed that E2-42 associated with E1 and E2. Our results indicate that E2-42 inhibits HCV entry via E1 and E2. These findings suggest a new avenue for HCV therapeutic development.Peiqi YinLing ZhangFei YeYao DengSha LuYi-Ping LiLeiliang ZhangWenjie TanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Peiqi Yin
Ling Zhang
Fei Ye
Yao Deng
Sha Lu
Yi-Ping Li
Leiliang Zhang
Wenjie Tan
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
description Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of overlapping peptides covering E1E2. Screening the peptide library identified several novel anti-HCV peptides. Four peptides from glycoprotein E2 were selected for further investigation. The 50% effective dose (ED50) was approximately 5 nM for each peptide. Our data indicated that these peptides inhibited HCV entry at the post-attachment step. Moreover, these peptides blocked cell-to-cell transmission of HCVcc and had broad-spectrum antiviral effects on HCVcc. These peptides exhibited combination inhibitory effects on HCVcc infection when combined with IFN-α2b or anti-CD81 antibody. Interestingly, we observed that E2-42 associated with E1 and E2. Our results indicate that E2-42 inhibits HCV entry via E1 and E2. These findings suggest a new avenue for HCV therapeutic development.
format article
author Peiqi Yin
Ling Zhang
Fei Ye
Yao Deng
Sha Lu
Yi-Ping Li
Leiliang Zhang
Wenjie Tan
author_facet Peiqi Yin
Ling Zhang
Fei Ye
Yao Deng
Sha Lu
Yi-Ping Li
Leiliang Zhang
Wenjie Tan
author_sort Peiqi Yin
title A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
title_short A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
title_full A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
title_fullStr A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
title_full_unstemmed A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
title_sort screen for inhibitory peptides of hepatitis c virus identifies a novel entry inhibitor targeting e1 and e2
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/14a535e894574041ba6a7a01d70ccb93
work_keys_str_mv AT peiqiyin ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT lingzhang ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT feiye ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT yaodeng ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT shalu ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT yipingli ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT leiliangzhang ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT wenjietan ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT peiqiyin screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT lingzhang screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT feiye screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT yaodeng screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT shalu screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT yipingli screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT leiliangzhang screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
AT wenjietan screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2
_version_ 1718394260170997760